Small Drop, Big Impact: Why Getting Blood Pressure to 120/80 Matters

Current NICE guidelines set a threshold of 135/85, but emerging evidence makes a compelling case for aiming lower, particularly in patients under 70. Achieving a blood pressure below 120/80 is associated with a 22% relative risk reduction in major adverse cardiovascular events (MACE) a clinically significant gain that deserves greater attention in primary care.

The Evidence: The SPRINT Trial

The Systolic Blood Pressure Intervention Trial (SPRINT)¹ directly compared a standard target of <140 mmHg against an intensive target of <120 mmHg. The results were striking. Patients in the intensive group achieved a 25% relative risk reduction in MACE including myocardial infarction, stroke, and heart failure alongside a 27% reduction in all-cause mortality. Notably, follow-up data from SPRINT MIND suggested the intensive target also reduced the risk of mild cognitive impairment, reinforcing that blood pressure control is as much a brain health intervention as a cardiac one.

For younger and middle-aged patients, the risk-benefit calculation favours the lower target. The current 135/85 threshold partly reflects caution around fall risk in older patients, a reasonable concern for those over 70. But for the under-70s, the case for tighter control is strong.

Crucially, this doesn't always mean more medication. The evidence for lifestyle intervention is now robust and quantified. Just 10–15 minutes of isometric exercise such as the plank or wall sit, performed as three sets repeated three times per week has been shown to reduce systolic blood pressure by 8–12 mmHg, equivalent to a standard antihypertensive agent.² The time commitment is modest; the physiological return is not.

Dietary modification offers similar gains. The DASH diet, when combined with sodium restriction below 1.5g per day, produces an average systolic reduction of 11 mmHg again, approaching monotherapy equivalence.³

Perhaps most striking is the synergy: combining isometric training with the DASH and low-sodium protocol can yield systolic reductions of 15–20 mmHg matching or exceeding what most single medications achieve.

For practices looking to shift the dial on cardiovascular outcomes, the message to patients is simple: small, sustained changes in how they move and eat can be as powerful as the pills we prescribe.

References

1. SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–2116. doi: 10.1056/NEJMoa1511939. Available at: https://www.nhlbi.nih.gov/science/systolic-blood-pressure-intervention-trial-sprint-study

2. Edwards JJ, Deenmamode AHP, Griffiths M, et al. Exercise training and resting blood pressure: a large-scale pairwise and network meta-analysis of randomised controlled trials. Br J Sports Med. 2023;57(20):1317–1326. doi: 10.1136/bjsports-2022-106503

3. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 2001;344(1):3–10. doi: 10.1056/NEJM200101043440101

Medicine Central is a clinical evidence review for UK primary care clinicians. Content reflects evidence current at time of publication and should be read alongside local formulary and clinical guidance. Guest contributors retain responsibility for the accuracy and originality of their work. Views expressed are the author's own and do not necessarily reflect those of Medicine Central. For healthcare professionals only.